Form 8-K - Current report:
SEC Accession No. 0001144204-13-040043
Filing Date
2013-07-18
Accepted
2013-07-18 08:25:51
Documents
3
Period of Report
2013-07-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v350240_8k.htm 8-K 30319
2 CERTIFICATE OF AMENDMENT OF THE RESTATED CERTIFICATE OF INCORPORATION v350240_ex3-1.htm EX-3.1 13290
3 EXHIBIT 99.1 v350240_ex99-1.htm EX-99.1 8763
  Complete submission text file 0001144204-13-040043.txt   53852
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 13973942
SIC: 2836 Biological Products, (No Diagnostic Substances)